NLS Pharmaceutics AG
NLSP0.762USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
3.16MMarket Cap
--P/E TTM
NLS Pharmaceutics AG Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-26.29
-106.12%
Analyst Rating
2025-05-19
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its Earnings Per Share (EPS) was -26.288, with a year-on-year change of -106.12%.
What is the net income of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its net income was -4.06M, with a year-on-year change of 66.67%.
What is the net margin of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its Return on Assets (ROA) was -97.10%, with a year-on-year change of 55.63%.
What is the operating profit of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its operating profit was -3.64M, with a year-on-year change of 69.20%.
What are the current assets of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its current assets were 2.23M, with a year-on-year change of 22.08%.
What are the total assets of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its total assets of NLS Pharmaceutics AG were 2.23M, with a year-on-year change of 20.93%.
What are the total liabilities of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its total liabilities of NLS Pharmaceutics AG were 826.76K, with a year-on-year change of -92.26%.
What is the total equity of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its total equity of NLS Pharmaceutics AG was 1.41M, with a year-on-year change of 115.92%.
What is the net operating income of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its net operating income of NLS Pharmaceutics AG was -1.98M, with a year-on-year change of 83.73%.
What is the net investment of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its net investment of NLS Pharmaceutics AG was -3.92K, with a year-on-year change of --.
What is the net financing of NLS Pharmaceutics AG?
According to NLS Pharmaceutics AG's FY2024 earnings report, its net financing of NLS Pharmaceutics AG was 5.04M, with a year-on-year change of 208.46%.
